FR2111895A1 - - Google Patents

Info

Publication number
FR2111895A1
FR2111895A1 FR7138657A FR7138657A FR2111895A1 FR 2111895 A1 FR2111895 A1 FR 2111895A1 FR 7138657 A FR7138657 A FR 7138657A FR 7138657 A FR7138657 A FR 7138657A FR 2111895 A1 FR2111895 A1 FR 2111895A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7138657A
Other languages
French (fr)
Other versions
FR2111895B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of FR2111895A1 publication Critical patent/FR2111895A1/fr
Application granted granted Critical
Publication of FR2111895B1 publication Critical patent/FR2111895B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B43/00—Preparation of azo dyes from other azo compounds
    • C09B43/32—Preparation of azo dyes from other azo compounds by reacting carboxylic or sulfonic groups, or derivatives thereof, with amines; by reacting keto-groups with amines
    • C09B43/38—Preparation of azo dyes from other azo compounds by reacting carboxylic or sulfonic groups, or derivatives thereof, with amines; by reacting keto-groups with amines by reacting two or more ortho-hydroxy naphthoic acid dyes with polyamines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FR7138657A 1970-10-28 1971-10-27 Expired FR2111895B1 (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5124270 1970-10-28
GB1478471 1971-05-13

Publications (2)

Publication Number Publication Date
FR2111895A1 true FR2111895A1 (enExample) 1972-06-09
FR2111895B1 FR2111895B1 (enExample) 1975-10-10

Family

ID=26250793

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7138657A Expired FR2111895B1 (enExample) 1970-10-28 1971-10-27

Country Status (8)

Country Link
BE (1) BE774108A (enExample)
CH (1) CH535248A (enExample)
ES (1) ES396350A1 (enExample)
FR (1) FR2111895B1 (enExample)
GB (1) GB1345327A (enExample)
IE (1) IE35780B1 (enExample)
LU (1) LU64101A1 (enExample)
NL (1) NL7114810A (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0220030A3 (en) * 1985-10-10 1987-09-30 Biotechnology Australia Pty. Ltd. Oral delivery system
US5807832A (en) * 1987-06-09 1998-09-15 Biotech Australia Pty Limited Oral delivery of biologically active substances bound to vitamin B12
US6159502A (en) * 1991-04-02 2000-12-12 Biotech Australia Pty Ltd Oral delivery systems for microparticles

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274564B1 (en) * 1996-09-18 2001-08-14 William J. Sarill Compositions of cobalamin and related corrinoids, and uses thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0220030A3 (en) * 1985-10-10 1987-09-30 Biotechnology Australia Pty. Ltd. Oral delivery system
US5428023A (en) * 1985-10-10 1995-06-27 Biotechnology Australia Pty. Ltd. Oral delivery of biologically active substances bound to vitamin B12 or analogues thereof
US5589463A (en) * 1985-10-10 1996-12-31 Biotechnology Autralia Pty., Ltd. Oral delivery of biologically active substances bound to vitamin B12
US5807832A (en) * 1987-06-09 1998-09-15 Biotech Australia Pty Limited Oral delivery of biologically active substances bound to vitamin B12
US6159502A (en) * 1991-04-02 2000-12-12 Biotech Australia Pty Ltd Oral delivery systems for microparticles

Also Published As

Publication number Publication date
FR2111895B1 (enExample) 1975-10-10
IE35780B1 (en) 1976-05-26
LU64101A1 (enExample) 1973-05-03
CH535248A (fr) 1973-03-31
NL7114810A (enExample) 1972-05-03
BE774108A (fr) 1972-04-18
ES396350A1 (es) 1974-05-01
GB1345327A (en) 1974-01-30
IE35780L (en) 1972-04-28

Similar Documents

Publication Publication Date Title
FR2080959A2 (enExample)
FR2077189B1 (enExample)
FR2077074A5 (enExample)
FR2073314A1 (enExample)
FR2089887A5 (enExample)
FR2080494A5 (enExample)
FR2085027A5 (enExample)
FR2076791A5 (enExample)
FR2086152A1 (enExample)
FR2090000A5 (enExample)
FR2080236A5 (enExample)
FR2080917A1 (enExample)
FR2111895B1 (enExample)
CS174824B2 (enExample)
FR2079302A7 (enExample)
FR2084076A5 (enExample)
FR2087181A5 (enExample)
FR2090232A1 (enExample)
FR2085364A7 (enExample)
FR2080909B1 (enExample)
FR2086572A5 (enExample)
FR2087046A5 (enExample)
FR2081124B1 (enExample)
FR2081046B1 (enExample)
FR2088811A5 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse